This inventor holds 8 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Abbott Gmbh & Co Kg, Basf Aktiengesellschaft, Abbott Laboratories Corporation. Active years: 2000-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Bruhl, DE (2000 - 2002)
- Brühl, DE (2006 - 2014)
Company Filing History:
4 out of 140 
2 out of 10,816 
1 out of 4,189 
Years Active: 2000-2014
Title: The Innovations of Hans-Jörg Treiber
Introduction
Hans-Jörg Treiber is a notable inventor based in Brühl, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of drugs for treating renal function disorders. With a total of 8 patents to his name, Treiber's work has had a meaningful impact on medical science.
Latest Patents
Among his latest patents, one invention focuses on the use of dopamine D receptor ligands for the production of drugs aimed at treating renal function disorders. Another patent involves substituted amides, detailing their preparation and use, including an amide of a specific formula and its various forms, as well as possible physiologically tolerated salts.
Career Highlights
Treiber has worked with prominent companies in the pharmaceutical industry, including Abbott GmbH & Co. KG and AbbVie Deutschland GmbH & Co. KG. His experience in these organizations has allowed him to refine his expertise and contribute to innovative drug development.
Collaborations
Throughout his career, Treiber has collaborated with esteemed colleagues such as Dorothea Starck and Wilfried Lubisch. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Hans-Jörg Treiber's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of treatments for renal function disorders, showcasing the importance of innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile